x

    Book Now

    Products & Pipeline

    Biosimilar Pipeline

    Project Code
    Therapeutic Area
    Cell line & Process Development
    Preclinical
    Clinical
    Submission
    Approval
    RELEUKO
    Oncology Supportive Care
    FYLNETRA
    Oncology Supportive Care
    ADL-018
    Immunology & Respiratory
    KSHB001
    Digestive Care
    KSHB002
    Immunology
    KSHB004
    Cardiovascular
    KSHB005
    Undisclosed
    KSHB006
    Undisclosed
    KSHB010
    Undisclosed
    KSHB007
    Fertility Hormone

    Complex Programs

    505(b)(2) Pipeline

    Project Code
    Therapeutic Area
    Early-stage development
    Late-stage development
    KSHS003
    Oncology
    KSHS002
    Gaucher’s Disease

    Generic Peptides Pipeline

    Project Code
    Therapeutic Area
    Early-stage development
    Late-stage development
    KSHG004
    Fertility Peptide
    KSHG005
    Fertility Peptide
    KSHG006
    Long acting peptide
    KSHG007
    Anti Diabetic (T2DM)

    NCEs Pipeline

    Project Code

    Therapeutic Area

    Proof Of Concept

    Hit and Lead Identification

    Lead Optimization

    Candidate Selection

    pre-IND & IND Enabling Studies

    IND Filing

    KSHN001

    Oncology (Oral Candidate)

    2022

    KSHN001

    Oncology (Injectable Candidate)

    2022

    KSHN002

    Interstitial Cystitis

    2023

    KSHN016

    Parkinson’s Disease

    TBD

    mRNA Therapy Pipeline

    Project Code
    Intervention Area
    Gene Synthesis
    Plasmid DNA
    mRNA
    Lipid Nanoparticle
    Immunogenicity Studies
    Preclinical Tox
    Clinical
    KSHV001
    Undisclosed
    KSHV003
    Undisclosed
    KSHV004
    Undisclosed
    KSHV005
    Undisclosed

    World Class Quality & Accuracy
    by Professional Experts

    Connect Now!